The Brink’s Company:企業の戦略・SWOT・財務情報

◆英語タイトル:The Brink's Company - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3696
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

The Brink’s Company – Strategy, SWOT and Corporate Finance Report
Summary

The Brink’s Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

The Brink’s Company (Brink’s or “the company”) is a provider of secure logistics and security solutions, including cash-in-transit, ATM replenishment and maintenance, international transportation of valuables, cash management and payment services. The company serves financial institutions, retailers, government agencies (including central banks), mints, jewelers and other commercial operations around the world. The company operates in the US, Latin America, Europe, Middle East and Africa (EMEA) and Asia. Brink’s is headquartered in Richmond, Virginia, the US

Scope

- Detailed information on The Brink’s Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting The Brink’s Company in the form of a SWOT analysis
- An in-depth view of the business model of The Brink’s Company including a breakdown and examination of key business segments
- Intelligence on The Brink’s Company’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about The Brink’s Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of The Brink’s Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess The Brink’s Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on The Brink’s Company’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
The Brink’s Company: Company Overview 9
The Brink’s Company: Overview and Key Facts 9
The Brink’s Company: Overview 9
The Brink’s Company: Key Facts 9
The Brink’s Company: Key Employees 11
The Brink’s Company: Key Employee Biographies 12
The Brink’s Company: Major Products and Services 17
The Brink’s Company: Company History 18
The Brink’s Company: Management Statement 21
The Brink’s Company: Locations and Subsidiaries 24
The Brink’s Company: Key Competitors 25
The Brink’s Company: Company Analysis 26
The Brink’s Company: Business Description 26
The Brink’s Company: SWOT Analysis 28
The Brink’s Company: SWOT Overview 28
The Brink’s Company: Strengths 28
The Brink’s Company: Weaknesses 29
The Brink’s Company: Opportunities 29
The Brink’s Company: Threats 29
The Brink’s Company: Corporate Financial Deals Activity 31
The Brink’s Company: Financial Deals Overview 31
The Brink’s Company: Targets and Partners 33
The Brink’s Company: Top Deals 2014 – 2018YTD* 34
The Brink’s Company: Advisors 35
The Brink’s Company: Top Legal Advisors 35
The Brink’s Company: Top Financial Advisors 35
The Brink’s Company: Mergers and Acquisitions 36
The Brink’s Company: Recent Developments 37
The Brink’s Company: News and Events Summary 37
The Brink’s Company: Corporate Governance 39
The Brink’s Company: Financial Deals 40
The Brink’s Company: Financial Performance 40
Appendix 43
Contact Us 43
Methodology 43
About MarketLine 44

List of Tables
Table 1: The Brink's Company: Key Facts
Table 2: The Brink's Company: Key Employees
Table 3: The Brink's Company: Locations and Subsidiaries
Table 4: The Brink's Company: Key Competitors
Table 5: The Brink's Company: Deal Activity by Deal Type - Volume (TTM*)
Table 6: The Brink's Company: M&A Activity by Geography (TTM*)
Table 7: The Brink's Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: The Brink's Company: M&A Average Deal Size - Value (US$m)
Table 9: The Brink's Company: Targets and Partners
Table 10: The Brink's Company: Top Deals 2014 - 2018YTD*
Table 11: The Brink's Company: Legal Advisor Ranking by Value (US$m)
Table 12: The Brink's Company: Financial Advisor Ranking by Value (US$m)
Table 13: The Brink's Company: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: The Brink's Company: M&A Activity by Geography (2014 - YTD*2018)
Table 15: The Brink's Company: News and Events Summary
Table 16: The Brink's Company: Corporate Governance
Table 17: The Brink's Company: Financial Deals
Table 18: The Brink's Company: Financial Performance

List of Figures
Figure 1: The Brink's Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: The Brink's Company: M&A Activity by Geography (TTM*)
Figure 3: The Brink's Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: The Brink's Company: M&A Average Deal Size - Value (US$m)
Figure 5: The Brink's Company: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: The Brink's Company: M&A Activity by Geography (2014 - YTD*2018)

★海外企業調査レポート[The Brink’s Company:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Diamyd Medical AB (DMYD B):製薬・医療:M&Aディール及び事業提携情報
    Summary Diamyd Medical AB (Diamyd), formerly Diamyd Therapeutics AB is a drug development company that offers diabetes vaccine. The company's diabetes products include Diamyd, an antigen-based immunotherapy for the treatment of autoimmune diabetes. Its pipeline products include GAD, GABA, and other …
  • Allscripts Healthcare Solutions Inc (MDRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Allscripts Healthcare Solutions Inc (Allscripts), formerly Allscripts-Misys Healthcare Solutions, Inc., is a provider of healthcare information technology solutions. The company’s major solutions include Electronic Health Records (EHR), Financial Management Solutions, Population Health Manag …
  • Portigon Ag:企業の戦略・SWOT・財務分析
    Portigon Ag - Strategy, SWOT and Corporate Finance Report Summary Portigon Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Advanced Biological Laboratories SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Advanced Biological Laboratories SA (ABL) is a medical data technology company that provides integrated software solutions for personalised medicine. The company offers TherapyEdge, a point of care, decision support software for healthcare professionals; and TherapyEdge Box systems, a web ba …
  • Logicor Europe Ltd:企業の戦略的SWOT分析
    Logicor Europe Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • RTI Surgical Inc (RTIX):企業の財務・戦略的SWOT分析
    Summary RTI Surgical Inc (RTI), formerly RTI Biologics Inc is a surgical implant company that offers biologic, metal and synthetic implants. The company’s products include spine implants, surgical specialties, sports medicine implants, cardiothoracic and orthobiologics. It offers spine implants such …
  • Enusa Industrias Avanzadas, S.A., S.M.E:企業の戦略的SWOT分析
    Enusa Industrias Avanzadas, S.A., S.M.E - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Murata Manufacturing Co Ltd (6981):企業の財務・戦略的SWOT分析
    Murata Manufacturing Co Ltd (6981) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary MDU Resources Group, Inc. (MDU) is an energy, and construction materials and services company. It mines aggregates and markets crushed stone, sand, gravel and related construction materials. The …
  • Straco Corporation Limited:企業の戦略・SWOT・財務情報
    Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Skyworks Solutions Inc (SWKS):企業の財務・戦略的SWOT分析
    Skyworks Solutions Inc (SWKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Wilson Vale:企業の戦略・SWOT・財務情報
    Wilson Vale - Strategy, SWOT and Corporate Finance Report Summary Wilson Vale - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Alnylam Pharmaceuticals Inc (ALNY)-製薬・医療分野:企業M&A・提携分析
    Summary Alnylam Pharmaceuticals Inc, (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines; cardiova …
  • Keppel Land Limited:企業の戦略・SWOT・財務情報
    Keppel Land Limited - Strategy, SWOT and Corporate Finance Report Summary Keppel Land Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • M3, Inc. (2413):企業の財務・戦略的SWOT分析
    M3, Inc. (2413) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Zenotech Laboratories Ltd (532039):企業の財務・戦略的SWOT分析
    Zenotech Laboratories Ltd (532039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Itochu Chemical Frontier Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Itochu Chemical Frontier Corp (ICF), formerly Ando Kaseihin KK, a subsidiary of Itochu Corporation, is a chemical company that manufactures and markets chemical products. The company’s business division includes intermediate chemical division, performance product division, eco chemical and l …
  • Synairgen Plc (SNG):製薬・医療:M&Aディール及び事業提携情報
    Summary Synairgen plc (Synairgen) is a drug discovery and development company, which focuses on the development of novel drugs for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Its pipeline portfolio includes inhaled interferon beta (IFN-ß/SNG …
  • Otsuka Pharmaceutical Co., Ltd.:企業のM&A・事業提携・投資動向
    Otsuka Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Otsuka Pharmaceutical Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • JW Pharmaceutical Corp (001060):製薬・医療:M&Aディール及び事業提携情報
    Summary JW Pharmaceutical Corp (JW Pharmaceutical), a subsidiary of JW Holdings Corp is a provider of generic drugs. The company develops and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, and others. It offers multivitamins and antianemic agent …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆